All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a healthcare professional.

  TRANSLATE

The PsOPsA Hub website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and the PsOPsA Hub cannot guarantee the accuracy of translated content. The PsOPsA Hub and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help.

The PsOPsA Hub is an independent medical education platform. This activity is supported by an educational grant from Lilly. Funders are allowed no direct influence on our content.

Now you can support HCPs in making informed decisions for their patients

Your contribution helps us continuously deliver expertly curated content to HCPs worldwide. You will also have the opportunity to make a content suggestion for consideration and receive updates on the impact contributions are making to our content.

Find out more

Characteristics associated with MRI-confirmed axial PsA: Post hoc analysis of the phase IV STAR study

By Amy Hopkins

Share:

Nov 17, 2026

Learning objective: After reading this article, learners will be able to cite a new clinical development in psoriatic arthritis.


Results from an exploratory post hoc analysis of the randomized, placebo-controlled, phase IV STAR study (NCT04929210), evaluating guselkumab in patients with active psoriatic arthritis (PsA), were published in the Journal of Psoriasis and Psoriatic Arthritis by Baraliakos et al. This analysis assessed demographic and clinical characteristics associated with magnetic resonance imaging (MRI)-confirmed axial inflammation.

Key data: Among 487 screened patients, 433 had available MRI scores for both the sacroiliac joints (SIJ) and spine. Patients with both SIJ and spine MRI-positive findings (SIJ+/Spine+; n = 65) had higher mean C-reactive protein (CRP) levels (2.3 vs 1.4 mg/dL; nominal p < 0.05) and spinal pain scores (7.8 vs 7.3; nominal p < 0.05), and lower mean swollen joint count (SJC; 6.6 vs 8.1; nominal p < 0.05) and tender joint count (TJC; 11.1 vs 15.6; nominal p < 0.05) vs patients who were SIJ−/spine− (n = 257). Male sex was significantly associated with MRI-confirmed axial inflammation (odds ratio [OR], 3.96; 95% confidence interval [CI], 2.14–7.34). 

Key learning: In this post hoc analysis, male sex and elevated CRP levels were significantly associated with MRI-confirmed SIJ and spinal inflammation in patients with active PsA. These exploratory findings may support the development of formal classification criteria for axial PsA, though results require confirmation from the fully enrolled STAR population. 

References

Please indicate your level of agreement with the following statements:

The content was clear and easy to understand

The content addressed the learning objectives

The content was relevant to my practice

I will change my clinical practice as a result of this content

This content is accurate as of the date of publication and is not updated retrospectively. Please refer to the latest available evidence, guidelines, and relevant regulatory information when making clinical decisions.